resistant starch (high fiber muffin top)
OtherMuffin top contained 11 g of fiber per portion
NCT Number: NCT03252704
This randomized, double-blind, comparator controlled trial evaluated the blood glucose and insulin responses in healthy adults, after consuming a high fiber or low fiber muffin top.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
The fiber administered in this trial is a resistant starch type 4 derived from high-amylose maize starch. This product is high in dietary fiber (70% total dietary fiber (TDF), AOAC 2009.01 method) and can be used in a variety of bakery applications. The objective of this study was to evaluate the post-prandial blood glucose and insulin responses of healthy adults (n=28) after consuming a muffin top made with resistant starch or control muffin top, in a randomized, double-blind, crossover study. The muffin tops were matched for total weight, total carbohydrate, sugars, protein, and fat. During each 24-hour study period, subjects consumed a standard evening meal, fasted for 12 hours, and arrived at the study clinic the following morning. Serum glucose, serum insulin, and capillary glucose were measured after muffin top consumption. The subjects completed a seven day washout between treatments.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Muffin top contained 11 g of fiber per portion
Muffin top contained 1 g of fiber per portion
Time frame: 0-4 hours after consumption
IV and capillary
Time frame: 0-4 hours after consumption
IV
Time frame: 0-24 hours after consumption
Expired air
Ingredion Incorporated
Industry
Post-prandial Glucose and Insulin Response to High-fiber Muffin Top Containing Resistant Starch in Healthy Adults
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04230694
Diabetes, Diabetes Mellitus
Temple, Texas, United States
View Trial DetailsNCT03708939
Glucose Intolerance, Glucose Metabolism Disorders
Rehovot, Israel
View Trial DetailsNCT04648397
Glucose, High Blood, Glucose, Low Blood
Wageningen, Gelderland, Netherlands
View Trial DetailsNCT03344185
Diet Modification, Glucose, High Blood
View Trial Details